The most recent U.S. population data released by the Centers for Disease Control and Prevention (CDC) and from the U.S. Census at year-end 2021 includes the first ten months of the COVID-19 pandemic in the U.S. While we know the pandemic has had significant impacts on both the U.S. population and insured population mortality, we also see increased mortality due to many other non-COVID causes of death. Where are the biggest changes and what does this non-COVID excess mortality mean over the next few years? Take part as anexpert panel hosts an interactive discussion to examine data from general population as well as from both individual life and group life experience studies to explore how these changes might spur innovation in underwriting, assumption setting and pricing.
By attending the session, you will be able to:
- Observe panelists as they demonstrate how to use large amounts of complex information to synthesize meaningful analysis and perform experience studies to assist in development of projections and assumptions.
- Compare changes in non-COVID causes of death between U.S. general population and individual and group life markets.
- Understand impact of non-COVID causes of death on future mortality.
- Identify potential innovation to assumption setting, pricing and underwriting processes.
TRACK: Spearheading innovation through change